Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Social Stream



Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): $149.93

-1.04 (-0.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add JAZZ to Watchlist
Sign Up

Industry: Biotech


Ranked

of 378

in industry

JAZZ PHARMACEUTICALS PLC (JAZZ) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering JAZZ PHARMACEUTICALS PLC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 15 $250 $172 $204.937 $153 33.95%
2021-11-11 15 $250 $172 $204.312 $153 33.54%
2021-11-16 15 $250 $172 $204.125 $153 33.42%
2021-12-17 14 $250 $172 $203.812 $153 33.21%
2021-12-20 14 $250 $172 $201.937 $153 31.98%
2022-01-06 14 $250 $172 $202.312 $153 32.23%
2022-01-13 14 $250 $172 $202.812 $153 32.56%
2022-01-23 14 $250 $172 $204.562 $153 33.7%
2022-02-11 12 $250 $172 $204.437 $153 33.62%
2022-02-25 11 $250 $172 $204.437 $153 33.62%
2022-03-02 12 $250 $172 $202.866 $153 32.59%
2022-03-04 14 $250 $172 $202.266 $153 32.2%
2022-03-28 14 $250 $174 $203.466 $153 32.98%
2022-04-22 14 $250 $174 $204.357 $153 33.57%
2022-04-28 14 $250 $174 $203.785 $153 33.19%
2022-05-06 14 $250 $174 $205.285 $153 34.17%
2022-06-02 15 $250 $174 $203.666 $153 33.12%
2022-06-14 16 $250 $174 $203.062 $153 32.72%
2022-08-01 15 $225 $174 $199.933 $153 30.68%
2022-09-17 16 $225 $183 $200.437 $153 31%
2022-09-21 16 $225 $148 $197.437 $153 29.04%
2022-09-29 15 $225 $170 $198.812 $153 29.94%
2022-10-20 14 $225 $170 $196.933 $153 28.71%
2022-11-02 14 $225 $170 $197.133 $153 28.85%
2022-11-11 16 $225 $180 $199.437 $153 30.35%

The Trend in the Analyst Price Target


Over the past 29 months, JAZZ's average price target has gone up $45.44.

JAZZ reports an average of 39.47% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-20 14 250 172 201.937 126.50 59.63%
2022-03-28 14 250 174 203.466 158.15 28.65%
2022-04-28 14 250 174 203.785 161.19 26.43%
2022-10-21 14 225 170 197.133 135.01 46.01%
2022-11-11 16 225 180 199.437 149.15 33.72%

JAZZ Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.38 12 2 2 0 0 16

The Trend in the Broker Recommendations


JAZZ's average broker recommendation rating improved by 0.43 over the prior 14 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for JAZZ as an investment opportunity.

  • In the context of all US stocks, JAZZ PHARMACEUTICALS PLC's average analyst price target is greater than 3215.48% of them.
  • JAZZ PHARMACEUTICALS PLC's number of analysts covering the stock is greater than 3245.63% of Pharmaceutical Products stocks.
  • In terms of how JAZZ PHARMACEUTICALS PLC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 688.25% of that group.
  • In the context of Pharmaceutical Products stocks, JAZZ PHARMACEUTICALS PLC's variance in analysts' estimates is lower than -724.87% of them.

In the Pharmaceutical Products industry, BMRN, VRTX, and RPRX are the three stocks most similar to JAZZ PHARMACEUTICALS PLC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding JAZZ using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8749 seconds.